{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:16:29Z","timestamp":1750997789514,"version":"3.41.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gilead Science (PL)"},{"name":"Gilead Sciences (PL)"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186131","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T18:39:02Z","timestamp":1510598342000},"page":"e0186131","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations \u2013 A message for Central and Eastern Europe"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-4462","authenticated-orcid":true,"given":"Justyna D.","family":"Kowalska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Ankiersztejn-Bartczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Siewaszewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/QAD.0b013e32834e8805","article-title":"Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy","volume":"26","author":"JD Kowalska","year":"2012","journal-title":"Aids"},{"issue":"9142","key":"ref2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group","volume":"352","author":"A Mocroft","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/157016211798038542","article-title":"Cost-effectiveness of antiretroviral therapy for prevention","volume":"9","author":"JG Kahn","year":"2011","journal-title":"Curr HIV Res"},{"unstructured":"Global AIDS Update 2016. UNAIDS. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/resources\/documents\/2016\/Global-AIDS-update-2016\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/resources\/documents\/2016\/Global-AIDS-update-2016<\/ext-link>.","key":"ref4"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy","volume":"316","author":"AJ Rodger","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/QAI.0000000000000605","article-title":"Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization","volume":"69","author":"CC Kerr","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref8","first-page":"245","article-title":"WHO Guide to Cost-Effectiveness Analysis","author":"T Tan-Torres Edejer","year":"2003"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/hiv.12175","article-title":"Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care (TAK) project","volume":"16","author":"M Ankiersztejn-Bartczak","year":"2015","journal-title":"HIV Med"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"e0162739","DOI":"10.1371\/journal.pone.0162739","article-title":"Poor Linkage to Care Despite Significant Improvement in Access to Early cART in Central Poland\u2014Data from Test and Keep in Care (TAK) Project","volume":"11","author":"JD Kowalska","year":"2016","journal-title":"PLoS One"},{"issue":"9585","key":"ref11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(07)60948-9","article-title":"Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study","volume":"370","author":"A Mocroft","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/QAD.0000000000000224","article-title":"Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals","volume":"28","year":"2014","journal-title":"AIDS"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/cid\/cit423","article-title":"The incidence of AIDS-defining illnesses at a current CD4 count &gt;\/ = 200 cells\/muL in the post-combination antiretroviral therapy era","volume":"57","author":"A Mocroft","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAD.0000000000000042","article-title":"Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons","volume":"28","author":"L Ryom","year":"2014","journal-title":"AIDS"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.7448\/IAS.15.2.17426","article-title":"Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"15","author":"K Petoumenos","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/1471-2334-13-471","article-title":"Non-AIDS defining cancers in the D:A:D Study\u2014time trends and predictors of survival: a cohort study","volume":"13","author":"SW Worm","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study","volume":"23","author":"N Friis-Moller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study","volume":"53","author":"B Hasse","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/hiv.12162","article-title":"Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations","volume":"15","author":"K Petoumenos","year":"2014","journal-title":"HIV Med"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/QAD.0000000000000307","article-title":"HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies","volume":"28","author":"A Lasry","year":"2014","journal-title":"AIDS"},{"issue":"1\u20132","key":"ref21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.20452\/pamw.2638","article-title":"General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland","volume":"125","author":"D Golicki","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0272989X02238300","article-title":"A meta-analysis of utility estimates for HIV\/AIDS","volume":"22","author":"TO Tengs","year":"2002","journal-title":"Med Decis Making"},{"issue":"9672","key":"ref23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"C When To Start","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2015.04.019","article-title":"High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013","volume":"63","author":"H Kovari","year":"2015","journal-title":"J Hepatol"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/597468","article-title":"Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal","volume":"48","author":"C Antiretroviral Therapy Cohort","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/ijc.29603","article-title":"Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort","volume":"137","author":"M Hleyhel","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"ref27","first-page":"1","article-title":"Koszty cukrzycy typu 2 w Polsce (Badanie CODIP)","volume":"5","author":"I Kinalska","year":"2004","journal-title":"Diabetologia Praktyczna"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"A331","DOI":"10.1016\/j.jval.2012.08.778","article-title":"Cost of chronic hepatis C (HCV) in Poland\u2013health care professional survey","volume":"15","author":"MP Kaczor","year":"2012","journal-title":"Value in health"},{"issue":"6","key":"ref29","first-page":"59","article-title":"Analiza kosztoefektywno\u015bci leczenia z\u0142ama\u0144 osteoporotycznych w powi\u0105zaniu z algorytmem FRAX na pr\u00f3bie populacji Polski","volume":"1","author":"J Amarowicz","year":"2015","journal-title":"Ortopedia Traumatologia Rehabilitacja, MEDSSPORTPRESS"},{"unstructured":"Obwieszczenie Prezesa G\u0142\u00f3wnego Urz\u0119du Statystycznego z dnia 31 pa\u017adziernika 2016 r. w sprawie szacunk\u00f3w warto\u015bci produktu krajowego brutto na jednego mieszka\u0144ca w latach 2012\u20132014 na poziomie wojew\u00f3dztw (NTS2) i podregion\u00f3w (NTS3) Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/stat.gov.pl\/sygnalne\/komunikaty-i-obwieszczenia\/lista-komunikatow-i-obwieszczen\/obwieszczenie-w-sprawie-szacunkow-wartosci-produktu-krajowego-brutto-na-jednego-mieszkanca-w-latach-2012-2014-na-poziomie-wojewodztw-nts2-i-podregionow-nts3,281,3.html\" xlink:type=\"simple\">http:\/\/stat.gov.pl\/sygnalne\/komunikaty-i-obwieszczenia\/lista-komunikatow-i-obwieszczen\/obwieszczenie-w-sprawie-szacunkow-wartosci-produktu-krajowego-brutto-na-jednego-mieszkanca-w-latach-2012-2014-na-poziomie-wojewodztw-nts2-i-podregionow-nts3,281,3.html<\/ext-link> Accessed 02August2017.","key":"ref30"},{"issue":"48","key":"ref31","doi-asserted-by":"crossref","first-page":"20642","DOI":"10.2807\/1560-7917.ES2013.18.48.20642","article-title":"Increase of new HIV diagnoses among men who have sex with men in Poland, 2000 to 2011","volume":"18","author":"M Rosinska","year":"2013","journal-title":"Euro Surveill"},{"issue":"3","key":"ref32","first-page":"855","article-title":"Risk behaviors for getting HIV infection among the Croatian men who have sex with men in 2007","volume":"35","author":"B Kolaric","year":"2011","journal-title":"Coll Antropol"},{"issue":"22","key":"ref33","first-page":"574","article-title":"National Center for Epidemiology","volume":"47","year":"2015","journal-title":"Hungarian Epinfo"},{"unstructured":"Institute of Public Health of the Slovak Republic. 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.uvzsr.sk\" xlink:type=\"simple\">www.uvzsr.sk<\/ext-link>.","key":"ref34"},{"unstructured":"St\u00e1tn\u00ed zdravotn\u00ed \u00fastav. Czech Republic. Zpr\u00e1va o v\u00fdskytu a \u0161\u00ed\u0159en\u00ed HIV\/AIDS za rok 2015. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.szu.cz\/tema\/prevence\/zprava-o-vyskytu-a-sireni-hiv-aids-za-rok-2015\" xlink:type=\"simple\">http:\/\/www.szu.cz\/tema\/prevence\/zprava-o-vyskytu-a-sireni-hiv-aids-za-rok-2015<\/ext-link>.","key":"ref35"},{"key":"ref36","article-title":"Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration\u2014a comprehensive meeting report","author":"JD Kowalska","year":"2016","journal-title":"HIV Med"},{"unstructured":"European AIDS Clinical Society Guidelines Version 8.1, October 2016. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html\" xlink:type=\"simple\">http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html<\/ext-link>","key":"ref37"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2016.09.007","article-title":"Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS)","volume":"38","author":"AJ Schmidt","year":"2016","journal-title":"Int J Drug Policy"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"e19936","DOI":"10.1371\/journal.pone.0019936","article-title":"Cost-effectiveness of HIV screening in STD clinics, emergency departments, and inpatient units: a model-based analysis","volume":"6","author":"VS Prabhu","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hiv.12349","article-title":"Cost-effectiveness analysis of tenofovir\/emtricitabine and abacavir\/lamivudine in combination with efavirenz or atazanavir\/ritonavir for treatment-naive adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial","volume":"17","author":"E Wilkins","year":"2016","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"ref41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/11587500-000000000-00000","article-title":"Cost effectiveness of darunavir\/ritonavir 600\/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK","volume":"28","author":"K Moeremans","year":"2010","journal-title":"Pharmacoeconomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:27:48Z","timestamp":1750984068000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186131"}},"subtitle":[],"editor":[{"given":"Matthew","family":"Law","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186131","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,11,13]]}}}